These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7093189)

  • 21. Inactivation of alpha-chymotrypsin by a bifunctional reagent, 2-bromomethyl-3, I-benzoxazin-4-one.
    Alazard R; Béchet JJ; Dupaix A; Yon J
    Biochim Biophys Acta; 1973 Jun; 309(2):379-96. PubMed ID: 4731968
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlations of the basicity of His 57 with transition state analogue binding, substrate reactivity, and the strength of the low-barrier hydrogen bond in chymotrypsin.
    Lin J; Cassidy CS; Frey PA
    Biochemistry; 1998 Aug; 37(34):11940-8. PubMed ID: 9718318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational dynamics in fluorophenylcarbamoyl-alpha-chymotrypsins.
    Kairi M; Gerig JT
    Biochim Biophys Acta; 1990 Jun; 1039(2):157-70. PubMed ID: 2364092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of chymotrypsin-trifluoromethyl ketone inhibitor complexes: comparison of slowly and rapidly equilibrating inhibitors.
    Brady K; Wei AZ; Ringe D; Abeles RH
    Biochemistry; 1990 Aug; 29(33):7600-7. PubMed ID: 2271520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
    Oleksyszyn J; Powers JC
    Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorine magnetic resonance studies of fluorine-substituted benzoyl chymotrypsins.
    Amshey JW; Bender ML
    Arch Biochem Biophys; 1983 Jul; 224(1):378-81. PubMed ID: 6870262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of alpha-chymotrypsin with an enzyme-activated n-nitrosoamide: active-site labeling by the naphthylmethyl cation.
    Li M; Luo W; White EH
    Arch Biochem Biophys; 1995 Jun; 320(1):135-40. PubMed ID: 7793972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of chymotrypsin by fluorinated alpha-keto acid derivatives.
    Parisi MF; Abeles RH
    Biochemistry; 1992 Oct; 31(39):9429-35. PubMed ID: 1327115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of alpha-chymotrypsin by a bifunctional reagent, 3,4-dihydro-3,4-dibromo-6-bromomethylcoumarin.
    Béchet JJ; Dupaix A; Yon J; Wakselman M; Robert JC; Vilkas M
    Eur J Biochem; 1973 Jun; 35(3):527-39. PubMed ID: 4730954
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of serine proteases by peptidyl fluoromethyl ketones.
    Imperiali B; Abeles RH
    Biochemistry; 1986 Jul; 25(13):3760-7. PubMed ID: 3527255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-(Halomethyl)-2-pyranones as irreversible inhibitors of alpha-chymotrypsin.
    Boulanger WA; Katzenellenbogen JA
    J Med Chem; 1986 Aug; 29(8):1483-7. PubMed ID: 3735315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrasonic studies of proton-transfer reactions at the catalytic site of alpha-chymotrypsin.
    Rogez D; Cerf R; Andrianjara R; Salehi ST; Fouladgar H
    FEBS Lett; 1987 Jul; 219(1):22-6. PubMed ID: 3036598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NMR studies of the alpha-chymotrypsin-(R)-1-acetamido-2-(4- fluorophenyl)ethane-1-boronic acid complex.
    Sylvia LA; Gerig JT
    Biochim Biophys Acta; 1993 Jun; 1163(3):321-34. PubMed ID: 8507671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinvestigation of the phenacyl bromide modification of alpha-chymotrypsin.
    Glover GI; Mariano PS; Petersen JR
    Biochemistry; 1976 Aug; 15(17):3754-60. PubMed ID: 8093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Halo enol lactones: studies on the mechanism of inactivation of alpha-chymotrypsin.
    Daniels SB; Katzenellenbogen JA
    Biochemistry; 1986 Mar; 25(6):1436-44. PubMed ID: 3964685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Labeling of the active site of alpha-chymotrypsin with N-nitroso-N-benzylacetamide and related compounds.
    Li M; Roswell DF; White EH
    Biochem Biophys Res Commun; 1993 Oct; 196(2):907-13. PubMed ID: 8240368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity in the alkylation of methionine at the active site of alpha-chymotrypsin by aromatic alpha-bromo amides.
    Lawson WB; Rao GJ
    Biochemistry; 1980 May; 19(10):2133-9. PubMed ID: 7378352
    [No Abstract]   [Full Text] [Related]  

  • 38. [Identification of a methionine residue as the reactive site for chymotrypsin in the double-headed proteinase inhibitor from the canine submandibular gland (author's transl)].
    Hochstrasser K; Fritz H
    Hoppe Seylers Z Physiol Chem; 1975 Dec; 356(12):1859-63. PubMed ID: 1213681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformations of N-(2-fluorophenyl)-N-phenylcarbamoyl-alpha-chymotrypsin.
    Kairi M; Keder NL; Gerig JT
    Arch Biochem Biophys; 1990 Jun; 279(2):305-14. PubMed ID: 2350178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urea denaturation of active-site spin-labeled -chymotrypsin.
    Berliner LJ
    Biochemistry; 1972 Jul; 11(15):2921-4. PubMed ID: 4339473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.